Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Catalent logo — more products. better treatments. reliably supplied. ™

Catalent

more products. better treatments. reliably supplied. ™

Founded 2007 United States Tampa, United States 12614 employees Post-IPO Debt Total: $1.15B Biotechnology, Manufacturing +2

General Information

Company Name Catalent
Founded Year 2007
Location United States Tampa, United States
Founders / Decision Makers
Team member
Employees 12614
Industries Biotechnology, Manufacturing, Pharmaceutical +1
Funding Stage Post-IPO Debt
Business Model B2B, Platform, B2B2B
Revenue Model Service Fee, Product Sales, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Catalent. To contact Catalent, visit catalent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Catalent compare?

A PDF of Catalent and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Catalent soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Oct 12, 2026

Catalent has secured a commercial supply agreement with Mantra™ to provide support for its innovative portfolio of single-serve OTC oral gels.

Catalent a competitor of yours? Have our desk watch it

About Catalent

Catalent, Inc., founded in 2007, has established itself as a powerhouse in the Biotechnology, Manufacturing, Pharmaceutical, and Supply Chain industries. Headquartered in the United States, this leading global contract development and manufacturing organization (CDMO) acts as a trusted partner for pharma, biotech, and consumer health companies worldwide.

Renowned for championing "missions that matter," Catalent focuses on patient-first principles, where they help bring over 100 new products to market annually. Their impressive track record includes supporting half of all FDA approvals over the past decade and producing over 60 billion doses per year at more than 40 global sites.

Their recent $600.00M Post-IPO Debt investment on 19 December 2023 underscores their financial robustness and commitment to leveraging advanced technologies that solve complex challenges. Investors eyeing opportunities in this sector will find Catalent's innovation, production scale, and patient-centric approach highly compelling.

Business keywords: Contract Development and Manufacturing Organization (CDMO), Drug Delivery Technologies, Biologics Proprietary Expression Technology, Sterile Drug Formulation, Oral Dose Formulation, Blow-Fill-Seal Technology, Clinical Trial Manufacturing, Analytical Chemical Testing, Cell-Based Testing, Regulatory Consulting, Packaging Services, Gene Therapy, Vaccine Production, Cell Therapy, Biopharmaceutical Development

Services & Products

End-to-End CDMO Services
Oral Dose Solutions
Biologics Development
Specialty Pharma Services
Clinical Supply Chain Management
Self-Care Product Development

Target Customers

Pharmaceutical Companies Biotech Companies Health and Wellness Brands Innovators in Pharma and Biotech

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $600.00M -
19 Dec 2023
Post IPO Debt $550.00M -
10 Feb 2021

Catalent Alternatives & Competitors

View All Alternatives
Catalent vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
Catalent vs
Upperton Pharma Solutions
Upperton Pharma Solutions United Kingdom

Your Integrated CDMO Specialist. Driven by experts, led by science.

Private Equity
123 employees
Biotechnology, Industrial
Compare Catalent vs Upperton Pharma Solutions
Catalent vs
JOINN Biologics US Inc.
JOINN Biologics US Inc. United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Compare Catalent vs JOINN Biologics US Inc.
View all alternatives

FAQ About Catalent

more products. better treatments. reliably supplied. ™
Catalent was founded in 2007.
Catalent is headquartered in Tampa, United States.
Catalent operates in Biotechnology, Manufacturing, Pharmaceutical and Supply Chain. Its work centres on Contract Development and Manufacturing Organization (CDMO), Drug Delivery Technologies, Biologics Proprietary Expression Technology and Sterile Drug Formulation. Its customers include Pharmaceutical Companies, Biotech Companies and Health and Wellness Brands.
Catalent has a B2B, Platform and B2B2B business model. Its revenue comes from Service Fee, Product Sales and Usage Based.
Catalent has approximately 12614 employees.
Catalent has completed 2 funding rounds, raising a total of $1.15B. The latest funding stage is Post-IPO Debt.
Catalent offers: End-to-End CDMO Services, Oral Dose Solutions, Biologics Development, Specialty Pharma Services, Clinical Supply Chain Management, Self-Care Product Development.
Top alternatives and competitors to Catalent include ProBio, Upperton Pharma Solutions, JOINN Biologics US Inc., LTS Lohmann Therapie-Systeme AG, IDT Biologika. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Catalent and ProBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Catalent, https://bouncewatch.com/company/catalent-pharma-solutions, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout